George Bobustuc
Experienced in Large-Cell Immunoblastic Lymphoma

Dr. George Bobustuc

Neurology
Endeavor Health
Endeavor Health Medical Group
880 W. Central Rd., Suite 7200, 
Arlington Heights, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Large-Cell Immunoblastic Lymphoma
Endeavor Health
Endeavor Health Medical Group
880 W. Central Rd., Suite 7200, 
Arlington Heights, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

George Bobustuc is a Neurologist in Arlington Heights, Illinois. Dr. Bobustuc is rated as an Experienced provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. His top areas of expertise are Brain Tumor, Astrocytoma, Glioblastoma, Glioma, and Awake Craniotomy.

His clinical research consists of co-authoring 13 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Carol Davila University Of Medicine, 1991
Residency
University of Texas-Southwestern at Dallas - Neurology, Neurology, 1998
Specialties
Neurology
Licenses
Internal Medicine in WI
Board Certifications
American Board Of Psychiatry And Neurology
United Council For Neurologic Subspecialties
Fellowships
University of Texas M.D. Anderson Cancer Center, Neurological Oncology, 2001
Hospital Affiliations
Northwest Community Hospital 1
Swedish Hospital
Northshore University Healthsystem - Evanston Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Network Health
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Endeavor Health Medical Group
880 W. Central Rd., Suite 7200, Arlington Heights, IL 60005
Call: 847-618-4430
Other Locations
Endeavor Health Medical Group
2650 Ridge Ave., Kellogg Cancer Center, Evanston, IL 60201
Call: 847-570-2112
Endeavor Health Medical Group
2180 Pfingsten Rd., Kellogg Cancer Center, Glenview, IL 60026
Call: 847-570-2112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Enrollment Status: Recruiting
Publish Date: January 12, 2026
Intervention Type: Drug
Study Drugs: Vismodegib, GSK2256098, Capivasertib, Abemaciclib
Study Phase: Phase 2
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2025
Intervention Type: Drug
Study Drugs: Berubicin, Lomustine
Study Phase: Phase 2
Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas
Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas
Enrollment Status: Active_not_recruiting
Publish Date: February 18, 2025
Intervention Type: Other, Drug
Study Drugs: Vemurafenib, Cobimetinib
Study Phase: Phase 2
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
Enrollment Status: Terminated
Publish Date: January 24, 2025
Intervention Type: Biological, Drug
Study Drugs: HSPPC-96, Bevacizumab
Study Phase: Phase 2
A Phase II, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Disulfiram and Copper Gluconate When Added to Standard Temozolomide Treatment in Patients With Newly Diagnosed Resected Unmethylated Glioblastoma Multiforme
A Phase II, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Disulfiram and Copper Gluconate When Added to Standard Temozolomide Treatment in Patients With Newly Diagnosed Resected Unmethylated Glioblastoma Multiforme
Enrollment Status: Terminated
Publish Date: October 03, 2024
Intervention Type: Drug, Dietary supplement
Study Drugs: Disulfiram, Temozolomide
Study Phase: Phase 2
Feasibility of Aromatherapy in an Awake Craniotomy Environment
Feasibility of Aromatherapy in an Awake Craniotomy Environment
Enrollment Status: Completed
Publish Date: October 03, 2024
Intervention Type: Drug
Study Drug: Lavender
Study Phase: Phase 1
View 9 Less Clinical Trials

13 Total Publications

An implantable, intracerebral osmotic pump for convection-enhanced drug delivery in glioblastoma multiforme.
An implantable, intracerebral osmotic pump for convection-enhanced drug delivery in glioblastoma multiforme.
Journal: Frontiers in oncology
Published: July 30, 2025
View All 13 Publications
Similar Doctors
Karan S. Dixit
Experienced in Large-Cell Immunoblastic Lymphoma
Dr. Karan S. Dixit
Hematology Oncology | Neurology | Hematology
Experienced in Large-Cell Immunoblastic Lymphoma
Dr. Karan S. Dixit
Hematology Oncology | Neurology | Hematology
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
 (22.7 miles away)
312-695-4360
Experience:
15+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Karan Dixit is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Dr. Dixit has been practicing medicine for over 15 years and is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. His top areas of expertise are Astrocytoma, Glioma, Brain Tumor, Glioblastoma, and Gastrostomy.

Jeffrey J. Raizer
Experienced in Large-Cell Immunoblastic Lymphoma
Dr. Jeffrey J. Raizer
Neurology | Hematology | Oncology
Experienced in Large-Cell Immunoblastic Lymphoma
Dr. Jeffrey J. Raizer
Neurology | Hematology | Oncology
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
 (22.7 miles away)
312-695-4360
Experience:
35+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jeffrey Raizer is a Neurologist and a Hematologist in Chicago, Illinois. Dr. Raizer has been practicing medicine for over 35 years and is rated as an Elite provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.

VIEW MORE LARGE-CELL IMMUNOBLASTIC LYMPHOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bobustuc's expertise for a condition
ConditionClose
    • Distinguished
    • Astrocytoma
      Dr. Bobustuc is
      Distinguished
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    • Atypical Teratoid Rhabdoid Tumor (ATRT)
      Dr. Bobustuc is
      Distinguished
      . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
      See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
    • Brain Tumor
      Dr. Bobustuc is
      Distinguished
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Bobustuc is
      Distinguished
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Ependymoma
      Dr. Bobustuc is
      Distinguished
      . Learn about Ependymoma.
      See more Ependymoma experts
    • Glioblastoma
      Dr. Bobustuc is
      Distinguished
      . Learn about Glioblastoma.
      See more Glioblastoma experts
    View All 15 Distinguished Conditions
    • Advanced
    • Brain Stem Cancer
      Dr. Bobustuc is
      Advanced
      . Learn about Brain Stem Cancer.
      See more Brain Stem Cancer experts
    • Chordoma
      Dr. Bobustuc is
      Advanced
      . Learn about Chordoma.
      See more Chordoma experts
    • Choroid Plexus Papilloma
      Dr. Bobustuc is
      Advanced
      . Learn about Choroid Plexus Papilloma.
      See more Choroid Plexus Papilloma experts
    • Craniopharyngioma
      Dr. Bobustuc is
      Advanced
      . Learn about Craniopharyngioma.
      See more Craniopharyngioma experts
    • Diffuse Midline Glioma H3 K27M-Mutant
      Dr. Bobustuc is
      Advanced
      . Learn about Diffuse Midline Glioma H3 K27M-Mutant.
      See more Diffuse Midline Glioma H3 K27M-Mutant experts
    • Dysembryoplastic Neuroepithelial Tumors (DNET)
      Dr. Bobustuc is
      Advanced
      . Learn about Dysembryoplastic Neuroepithelial Tumors (DNET).
      See more Dysembryoplastic Neuroepithelial Tumors (DNET) experts
    View All 12 Advanced Conditions
    • Experienced
    • Acoustic Neuroma
      Dr. Bobustuc is
      Experienced
      . Learn about Acoustic Neuroma.
      See more Acoustic Neuroma experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Bobustuc is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anti-NMDA Receptor Encephalitis
      Dr. Bobustuc is
      Experienced
      . Learn about Anti-NMDA Receptor Encephalitis.
      See more Anti-NMDA Receptor Encephalitis experts
    • Arachnoid Cysts
      Dr. Bobustuc is
      Experienced
      . Learn about Arachnoid Cysts.
      See more Arachnoid Cysts experts
    • Arteriovenous Malformation
      Dr. Bobustuc is
      Experienced
      . Learn about Arteriovenous Malformation.
      See more Arteriovenous Malformation experts
    • Awake Craniotomy
      Dr. Bobustuc is
      Experienced
      . Learn about Awake Craniotomy.
      See more Awake Craniotomy experts
    View All 61 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.